A*STAR BTI Spinoff AuctuCel Unveils AI Platform to Slash Cell Therapy Production Costs by as Much as 80%
AuctuCel, a biotechnology spinoff from A*STAR’s Bioprocessing Technology Institute (BTI), has officially launched with the debut of its proprietary Fluxperior platform, an artificial intelligence-driven system that promises to transform the…